A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

NCT06292780 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed/Refractory Systemic Light Chain Amyloidosis

Interventions

DRUG: Linvoseltamab

Sponsor

Regeneron Pharmaceuticals